by Ursula Tschorn | Apr 6, 2026 | Regulatory
Pharmaceutical import into Germany is governed by a precise regulatory framework that creates both obligations and opportunities for international traders. Whether you are pursuing parallel import, individual import under Article 73.3 AMG, or exploring niche products...
by Ursula Tschorn | Apr 6, 2026 | Regulatory
An eu drug authorization database is a consolidated platform that lets pharmaceutical professionals search marketing authorizations across multiple countries from a single interface. Instead of navigating dozens of national registries in different languages, you query...
by Ursula Tschorn | Apr 6, 2026 | Regulatory
A discontinued drugs Germany archive is one of the most overlooked resources in pharmaceutical business development. Every year, dozens of medicinal products are deleted from the German market — and as of March 2026, BfArM lists 562 active shortage entries, many...
by Ursula Tschorn | Nov 30, 2025 | Regulatory
Executive Summary In the contemporary healthcare ecosystem, the medication database has transcended its traditional role as a static repository of pharmaceutical nomenclature. It has evolved into a dynamic, mission-critical infrastructure that underpins patient...
by Ursula Tschorn | May 12, 2025 | Regulatory
In the pharmaceutical industry, having timely and accurate reimbursement data is crucial for successful market access across Europe. Especially in Germany, Austria, and Switzerland (DACH), you face a patchwork of pricing systems and databases. Navigating these can be...
by Ursula Tschorn | May 12, 2025 | Regulatory
Germany has been grappling with increasing medicine shortages in recent years. Ensuring a reliable drug shortage database in Germany is crucial for healthcare stakeholders to maintain patient care and plan effectively. Official figures show that medicine supply issues...
